Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

By H. Diener, J. Bogousslavsky, L. Brass, C. Cimminiello, L. Csiba, M. Kaste, D. Leys, J. Matías-Guiu, H. Rupprecht. The Lancet, 2004

2,195 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “However, the risk of life-threatening or major bleeding was significantly increased by the addition of aspirin.(478)”
Factors Influencing the Decline in Stroke Mortality (2013, background): “A randomized, controlled trial of aspirin and clopidogrel to prevent recurrent stroke in patients with ischemic stroke showed no benefit compared with clopidogrel alone.(314) Integrating all the evidence, current professional guidelines from the AHA/American Stroke Association suggest that either as”